|
US2021017160A1
|
|
DEUTERATED sGC STIMULATORS
|
|
US2021017161A1
|
|
DEUTERATED sGC STIMULATORS
|
|
CA3103676A1
|
|
Use of sgc stimulators for the treatment of mitochonrial disorders
|
|
CR20200457A
|
|
Process for preparing soluble guanylate cyclase stimulators
|
|
AU2019231724A1
|
|
Crystalline forms of an sGC stimulator
|
|
AU2019206560A1
|
|
Novel processes and intermediates for the preparation of soluble guanylate cyclase stimulators
|
|
KR20200100696A
|
|
sGC stimulant
|
|
EP3554488A2
|
|
Use of sgc stimulators for the treatment of esophageal motility disorders
|
|
EP3538520A2
|
|
Sgc stimulators
|
|
AU2017292811A1
|
|
Novel processes for preparation of soluble guanylate cyclase stimulators
|
|
AU2017291827A1
|
|
Novel processes for preparation of soluble guanylate cyclase stimulators
|
|
EP2897953A1
|
|
Sgc stimulators
|
